Issue link: http://osercommunicationsgroup.uberflip.com/i/1153034
Chain Drugstore Daily 1 9 Monday, August 26, 2019 Aurobindo to Acquire Dermatology and Oral Solids Businesses from Sandoz Inc., USA Aurobindo Pharma Limited, a world- leading marketer and manufacturer of generic pharmaceuticals and active phar- maceutical ingredients, announces the signing of a definitive agreement to acquire certain assets from Sandoz Inc., USA ("Sandoz"), a Novartis Division, comprising a market leading dermatol- ogy business and a portfolio of oral solid products along with commercial and manufacturing infrastructure in the U.S. The acquisition will be on a debt-free and cash-free basis and will be made through its wholly owned subsidiary, Aurobindo Pharma USA Inc. Aurobindo and Sandoz will enter into a transitional services agreement to support the ongoing growth plans of the businesses being acquired by Aurobindo. The transaction will be an all cash transaction which Aurobindo will finance through a fully committed debt facility. This U.S. acquisition is in line with Aurobindo's strategy to strengthen and grow its global business and to expand and enhance its product portfolio offer- ings in key therapeutic areas. The acqui- sition will give Aurobindo a market lead- ing dermatology franchise comprising a wide portfolio of generic and a range of branded products which are well recog- nized by patients, pharmacists and retail/wholesale customers. Aurobindo will also acquire a well-established com- mercial infrastructure with a fully-dedi- cated dermatology sales force along with a state-of-the-art manufacturing facility with specialized capabilities in creams, ointments, lotions, topi- cal solutions and topical suspensions that are highly complementary to Aurobindo's current manufacturing foot- print. The acquired generic dermatology portfolio covers a wide range of thera- peutic areas including topical antibiotics, gynaecological and dermatological anti- fungal agents, anti-acne agents, local anaesthetic analgesics, anti-itch, and a dermatological chemotherapeutic agent. The oral nondermatological portfolio that is being acquired spans a wide range of therapeutic areas including auto-immune disease, anti-neoplastic agents and a vari- ety of hormonal agents, among others. Aurobindo has grown its business focusing on vertical integration and its commitment to the needs of its diverse patient population. To support those needs, Aurobindo will leverage its strong scien- tific principles and extensive product portfo- lio, which is currently comprised of over 180 product families, and is excited for the addition of new therapeutic cate- gories to its existing portfolio. The company has experienced substantial growth over the past five years, moving from the eighth largest in the market in 2015 to now second. This growth has been largely organic, and now with the addition of Sandoz, this exponential growth has stamped Aurobindo's posi- tion as a leading generic pharmaceuti- cal manufacturer. Visit Aurobindo at booth #1951. For more information, contact your account manager, visit www.aurobindousa.com or call 866.850.2876. Omnipresence Isn't for Every Brand By Blake Marts, Director of Product Marketing, Inmar Occasionally in the advertising commu- nity we see enigmatic brands and prod- ucts – the type to whom direct competi- tion even tips its cap. Their logo alone, flashed briefly in a banner ad or slapped haphazardly in the front window of a gas station, can elicit consumer cravings and force desires that undoubtedly lead to an unplanned purchase. These brands are inherently every- where, with a global demand that nullifies price sensitivities and consistently neutral- izes threats to market share in their catego- ry. You may work for one of these brands, and if so, we're not here to suggest you have it easy. You face challenges, too; they're just dissimilar to the difficulties lesser-known companies often face. As opposed to these unicorns of commerce, yet-to-become-iconic brands are feverishly fighting to exist in the minds of consumers, penetrate new households and drive trial. For those with the resources to compete for attention, the goal is to be omnipresent – everywhere, at all times, with the right message. It's a task equally as challenging as quintessen- tial brands' efforts to win favor with the single-digit percentage of the population that doesn't know or like them. Is it efficient, though, to just be the loudest voice across all mediums and points-of-sale? We think not, and at Inmar we provide solutions that allow both challenger brands and their well- known foes to establish, grow and main- tain relevance among key audiences, without the need to touch every touch- point. Here are a few worth mentioning. One-to-One Conversation That Ends in a Purchase AI continues to make chatbot messaging more sophisticated, and we provide an end-to-end solution that not only allows for personalized interactions at scale, but also facilitates, authenticates and settles a purchase – all within the messag- ing environment. The best part? You can continually re-engage these opted-in users along their path to becoming your brand's most loyal customers. Influencer Marketing that Guarantees, Delivers and Quantifies Results While the industry has been challenged by fraudulent behavior of content cre- ators and claims of inefficiency by some marketers, Inmar has continuously served as the pacesetter for the industry as it seeks legitimacy and trust. Following the acquisition of Collective Bias in 2016, we have established the industry's brand safety and measurement standards, and built a performance-based pricing model that allows you to pur- chase influencer content like you would any other form of media. Offers that Offer More The universe of coupon distribution and settlement has seen drastic change in recent years, going from a focus on rela- tively untargeted placement in traditional publications, to a variety of seam- less digital formats more intuitive for consumers and data-driven for marketers. We were on the fore- front of this transition, and our Digital Promotions Network is proven to drive profitable growth. No brand, even the aforementioned uni- corn, has the unlimited resources (time or money) to truly become omnipresent. Moreover, today's consumer doesn't want you to be front-and-center throughout their day. As you plan for 2020 and beyond, ask yourself if the dis- parate pieces of your marketing plan are designed to be tailored to the behavior and preferences of individuals through- out their journey, or if it's simply check- ing boxes and allowing you to say you're "there," wherever "there" may be. We are here to help you answer these questions, and power tech-enabled solu- tions that create better outcomes. Curious how we do it? Let's talk. For more information, visit booth #1151.